Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
TRDA
$7.46
+0.13%
TRDA · Entrada Therapeutics, Inc.
$7.46
+0.01 (+0.13%)
At close · Aug 14
Market Cap
$290.47M
Shares
38.94M
All earnings calls
Earnings call · FY2025 Q4
Entrada Therapeutics, Inc. Q4 FY2025 Earnings Call
Entrada Therapeutics, Inc. Q4 FY2025 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$1.30M
-96.5% YoY
Net income · derived Q4
-$39.16M
-3562.8% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 8, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 26, 2026 · complete as-filed document